The pharmaceutical manufacturing market is shifting towards advanced technologies, expanding biosimilar production, and diversifying supply chains across regions to meet growing global demand and adhere to stricter regulations. This momentum is driven by the cost benefits of continuous processing, incentives for reshoring, and AI-powered quality control systems that reduce time-to-market and support flexible production needs. CDMOs are rapidly expanding to cater to the rising demand for biologics, North American firms are investing heavily in domestic manufacturing capacity, and Asia-Pacific governments are enhancing their regulatory frameworks. Together, these factors are setting the stage for the market to achieve sustained double-digit growth.

Market Outlook & Growth Forecast

The global market is expected to reach USD 505.97 billion in 2025, and with a CAGR of 9.89%, it is projected to grow to USD 810.67 billion by 2030

This robust expansion is driven by increased pharmaceutical R&D investment, advanced technological adoption, and rising demand from aging populations and chronic‑disease prevalence.

Key Market Drivers & Industry Trends

Technological Adoption: Manufacturers are investing in continuous‑processing, automation, AI‑enabled quality control, and advanced biologics manufacturing methods to enhance efficiency and compliance

CDMO Surge: Contract Development and Manufacturing Organizations (CDMOs) are scaling rapidly, supported by shifting supply chains, regulatory incentives, and offshore manufacturing diversification.

Regulatory & Reshoring Momentum: North American firms are bolstering domestic capacity, while Asia–Pacific nations are refining regulatory frameworks collectively enhancing global pharmaceutical resilience

Segment Insights

Mode of Manufacturing:

In‑house production leads with a 59.4% share (2024); CDMOs are anticipated to grow at 10.84% CAGR through 2030

Molecule Type:

Small‑molecule drugs account for 61.3% of revenue (2024), while biologics and biosimilars advance at a 10.34% CAGR

Product Form:

Tablets dominate with a 33.6% share (2024); injectables are on fast track, growing at 11.13% CAGR

Manufacturing Technology:

Traditional batch processes hold 74.6% share (2024); continuous manufacturing is growing at 12.25% CAGR

Therapeutic Area:

The oncology segment led with 27.8% share (2024) and is expanding at 13.84% CAGR

Prescription Types:

Prescription drugs make up 83.7% of the market (2024); OTC medications are rising at 11.87% CAGR


Regional Landscape

North America remains the largest regional market, driven by production scale, mature infrastructure, and policy support.

Asia–Pacific is the fastest-growing region, fuelled by manufacturing expansion, regulatory evolution, and export orientation.


Market Outlook

Looking ahead, the pharmaceutical manufacturing sector is poised for continued transformation:

Advanced Manufacturing – Surge in continuous processing, modular plants, AI‑enabled quality systems.

CDMO Shift – Outsourced capacity for biologics, generics, and specialty formulations is on the rise.

Supply‑chain Diversification – Domestic investments in North America coupled with APAC regulatory reinforcement.

Therapeutic Focus – Oncology and biologics continue to be dominant, driving sophisticated production needs.


Get More Insights: https://www.mordorintelligence.com/industry-reports/pharmaceutical-manufacturing?utm_source=prfree

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

[email protected]
https://www.mordorintelligence.com/